JENNIFER JOSES: Open Payments
NPI 1275588717 · SAN ANDREAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 17 payments from 8 companies in 2025. Trend: 2023 $447 · 2024 $273 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $93 |
| Novo Nordisk Inc | 4 | $83 |
| Exact Sciences Corporation | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Braintree Laboratories, Inc. | 1 | $33 |
| Antares Pharma, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: MOUNJARO, The Cologuard Plus Collection Kit, Ozempic, Rybelsus, Kerendia, SUTAB, XYOSTED, Korlym.
Industry payments across CA — which companies pay providers there.
